ストックスクリーナーアプリを入手
1.52
2.56%
-0.04
アフターアワーズ：
1.49
-0.03
-1.97%
Proqr Therapeutics N V (PRQR) 最新ニュース
ETFs Investing in ProQR Therapeutics N.V. Stocks - TradingView
ProQR Therapeutics (PRQR) Advances 3% as Biotech Sector Sentiment ImprovesPCR Extreme - newsline.com
Undervalued Penny Stocks To Consider In June 2026 - simplywall.st
Van Herk group (NASDAQ: PRQR) challenges ProQR 2026 AGM share capital proposals - Stock Titan
ProQR Therapeutics N.V. (PRQR) director awarded 14,495 stock options as compensation - Stock Titan
ProQR Shareholders Approve Capital Increase, Board Changes at 2026 AGM - TipRanks
ProQR (PRQR) director Hinsch Gylvin Lykke files Form 3 with no share activity - Stock Titan
ProQR Therapeutics N.V. Appoints Lykke Hinsch Gylvin as Non-Executive Member of the Board, Effective June 2, 2026 - marketscreener.com
PRQR News | PROQR THERAPEUTICS NV (NASDAQ:PRQR) - ChartMill
PRQR Stock Price, Quote & Chart | PROQR THERAPEUTICS NV (NASDAQ:PRQR) - ChartMill
ProQR Therapeutics Holds Steady Above Support; Small Uptick Signals StabilityBullish Pattern Stocks - The Legal Advocate
Citizens reiterates ProQR stock rating on biliary atresia potential By Investing.com - Investing.com Australia
Citizens reiterates ProQR stock rating on biliary atresia potential - Investing.com
ProQR Therapeutics (PRQR) Holds Steady Near $1.57 as Uplift Potential RemainsDaily Profile - The Legal Advocate
ProQR (PRQR) Eyes Next Move After Holiday Ahead of AX-0810 Data - Bez Kabli
ProQR Therapeutics Q1 2026 Earnings: Narrower Net Loss, No Revenue as Pipeline Progress Drives Stock GainsWall Street Picks - Newser
Cash per share of ProQR Therapeutics N.V. – LS:A12B97 - TradingView
ProQR Therapeutics Q1 2026 Earnings: Narrower Loss on Continued Pipeline ProgressEarnings Quality Score - newsline.com
ProQR Therapeutics N.V. (PRQR) Presents at 29th ASGCT Annual Meeting 2026Slideshow - Seeking Alpha
ProQR Therapeutics N.V. (PRQR) Presents at TIDES USA 2026Slideshow (NASDAQ:PRQR) 2026-05-15 - Seeking Alpha
ProQR Therapeutics N.V.Ordinary Shares (NQ: PRQR - The Chronicle-Journal
ProQR Therapeutics N.V. (NASDAQ:PRQR) Analysts Just Slashed This Year's Revenue Estimates By 22% - Yahoo Finance
ProQR Posts Wider Q1 2026 Loss but Maintains Strong Cash Position - The Globe and Mail
ProQR Therapeutics Releases Q1 2026 Financial Results - AlphaStreet
ProQR Posts Q1 2026 Results as Axiomer RNA Editing Pipeline Advances - TipRanks
ProQR Announces First Quarter 2026 Operating and Financial Results - The Manila Times
ProQR (Nasdaq: PRQR) Q1 2026 results, Axiomer pipeline and cash runway - Stock Titan
ProQR (Nasdaq: PRQR) updates AX-0810 strategy and Q1 2026 results - Stock Titan
ProQR Therapeutics N.V. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
TradingKey - TradingKey
ProQR Announces Multiple Upcoming Scientific Conference Presentations Highlighting the Breadth of its Axiomer™ RNA Editing Platform - The Manila Times
ProQR Announces Multiple Upcoming Scientific Conference - GlobeNewswire
MSN Money - MSN
Number of shareholders of ProQR Therapeutics N.V. – LS:A12B97 - TradingView
ProQR Therapeutics (PRQR) to Release Quarterly Earnings on Thursday - MarketBeat
ProQR Sets June 2, 2026 Date for Annual General Meeting of Shareholders - The Globe and Mail
ProQR forms advisory board, partnership with Ginkgo as part of AI strategy - MSN
ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026 - markets.businessinsider.com
ProQR Therapeutics NV expected to post a loss of 12 cents a shareEarnings Preview - TradingView
ProQR Therapeutics N : AGM 2026 POA Registered Shareholders - marketscreener.com
ProQR sets June 2 shareholder meeting, posts agenda documents online - Stock Titan
ProQR (PRQR) 2026 AGM to expand share capital, issuance and buyback powers - Stock Titan
ProQR Announces Annual General Meeting of Shareholders to Be Held June 2, 2026 - Moomoo
ProQR Nominates Boehringer Ingelheim CMO Lykke Hinsch Gylvin to Board to Support Next Growth Phase - The Globe and Mail
1.27%
1.43%
大文字化:
|
ボリューム (24 時間):